BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10816058)

  • 1. Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery.
    Olsson C; Siegbahn A; Henze A; Nilsson B; Venge P; Joachimsson PO; Thelin S
    Scand Cardiovasc J; 2000; 34(1):33-40. PubMed ID: 10816058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits.
    Borowiec JW; Hagman L; Tötterman TH; Pekna M; Venge P; Thelin S
    Scand J Thorac Cardiovasc Surg; 1995; 29(4):167-74. PubMed ID: 8789469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass.
    Kagisaki K; Masai T; Kadoba K; Sawa Y; Nomura F; Fukushima N; Ichikawa H; Ohata T; Suzuki K; Taketani S; Matsuda H
    Artif Organs; 1997 Jul; 21(7):836-40. PubMed ID: 9212969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
    Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
    Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits.
    Olsson C; Siegbahn A; Haldén E; Nilsson B; Venge P; Thelin S
    Ann Thorac Surg; 2000 Mar; 69(3):743-9. PubMed ID: 10750754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V
    Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study.
    Fosse E; Thelin S; Svennevig JL; Jansen P; Mollnes TE; Hack E; Venge P; Moen O; Brockmeier V; Dregelid E; Haldén E; Hagman L; Videm V; Pedersen T; Mohr B
    Eur J Cardiothorac Surg; 1997 Feb; 11(2):320-7. PubMed ID: 9080162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass.
    Steinberg BM; Grossi EA; Schwartz DS; McLoughlin DE; Aguinaga M; Bizekis C; Greenwald J; Flisser A; Spencer FC; Galloway AC
    Ann Thorac Surg; 1995 Sep; 60(3):525-9. PubMed ID: 7677475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits.
    Ernofsson M; Thelin S; Siegbahn A
    Scand J Thorac Cardiovasc Surg; 1995; 29(4):157-65. PubMed ID: 8789468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-bonded cardiopulmonary bypass circuits reduce cognitive dysfunction.
    Heyer EJ; Lee KS; Manspeizer HE; Mongero L; Spanier TB; Caliste X; Esrig B; Smith C
    J Cardiothorac Vasc Anesth; 2002 Feb; 16(1):37-42. PubMed ID: 11854876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
    Aldea GS; Soltow LO; Chandler WL; Triggs CM; Vocelka CR; Crockett GI; Shin YT; Curtis WE; Verrier ED
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.
    Ashraf S; Tian Y; Cowan D; Entress A; Martin PG; Watterson KG
    Ann Thorac Surg; 1997 Dec; 64(6):1790-4. PubMed ID: 9436574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation during cardiopulmonary bypass: effects of immobilized heparin.
    Pekna M; Hagman L; Haldén E; Nilsson UR; Nilsson B; Thelin S
    Ann Thorac Surg; 1994 Aug; 58(2):421-4. PubMed ID: 8067842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
    Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
    Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
    Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study.
    Wan S; LeClerc JL; Antoine M; DeSmet JM; Yim AP; Vincent JL
    Ann Thorac Surg; 1999 Oct; 68(4):1230-5. PubMed ID: 10543484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children.
    Ozawa T; Yoshihara K; Koyama N; Watanabe Y; Shiono N; Takanashi Y
    Ann Thorac Surg; 2000 Feb; 69(2):584-90. PubMed ID: 10735703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
    Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
    Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance and biocompatibility of hyaluronan-based heparin-bonded extracorporeal circuits in different risk cohorts.
    Gunaydin S; McCusker K; Sari T; Onur MA; Zorlutuna Y
    Interact Cardiovasc Thorac Surg; 2010 Mar; 10(3):371-6. PubMed ID: 20026488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.